Laura Blanchard

University of North Carolina at Chapel Hill — United States

Medicine · Health Sciences

3h-index54citations6works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(4), CAR-T cell therapy research(2), Histone Deacetylase Inhibitors Research(2), Protein Degradation and Inhibitors(2), Cancer Immunotherapy and Biomarkers(1)

Publications6 total

Final Clinical Results of a Phase II Study of High Dose Cytarabine Followed By Pembrolizumab in Relapsed/Refractory AML
Blood·2019· 33 cited
Genomics Reveal Potential Biomarkers of Response to Pembrolizumab after High Dose Cytarabine in an Ongoing Phase II Trial in Relapsed/Refractory AML
Blood·2018· 7 cited
Clonal evolution of Philadelphia chromosome in acute myeloid leukemia after azacitidine treatment
Leukemia & lymphoma/Leukemia and lymphoma·2018· 2 cited
Phase II Study of High Dose Cytarabine Followed By Pembrolizumab in Relapsed/Refractory Acute Myeloid Leukemia (AML)
Blood·2017· 10 cited
Drug use and risky sexual behavior.
Psychology of Addictive Behaviors·1994· 2 cited
The Arthurian Tradition: The Myths and Realities of the Arthurian Legends (review)
Arthuriana·1988

Frequent Co-authors

Joshua F. Zeidner(4), Matthew C. Foster(4), Cassiopeia Frank(4), Sean Gallagher(4), Melissa Matson(4), Benjamin G. Vincent(3), Anastasia Ivanova(3), Catherine C. Coombs(3), Katarzyna Jamieson(3), Nancy Vogler(3), Leo Luznik(3), Jonathan S. Serody(3), Ivana Gojo(3), Katherine Pepin(3), L Vaught(3), Hendrik W. van Deventer(2), Sonia Esparza(1), Dominic T. Moore(1), William Churchwell(1), Ashley Reed(1)